戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 122 HCCs, 18 non-HCC malignancies, and three benign nodules).
2                        Thirty patients had a benign nodule.
3 alignant non-calcified nodules and one had a benign nodule.
4         No participant had thoracotomy for a benign nodule.
5 ion of cancer while minimizing testing for a benign nodule.
6 +/- 0.19 vs. 1.46 +/- 0.87; P = 0.1295) than benign nodules.
7 optimal discrimination between malignant and benign nodules.
8 e TSHR variants detected, (6/7, 86%) were in benign nodules.
9  1.00) for differentiation of malignant from benign nodules.
10 ents, it was ultimately proven that they had benign nodules.
11 ncreased their detection of lung cancers and benign nodules.
12 nditions, including histologically diagnosed benign nodules.
13 ign and malignant nodules; 17 (42%) had only benign nodules.
14 ules that require surgery, and 98.6% NPV for benign nodules.
15 differentiating small malignant nodules from benign nodules.
16 lignant, three high-grade dysplastic, and 20 benign nodules.
17  costs of diagnosis compared to lobectomy in benign nodules.
18 tiation of HCC from non-HCC malignancies and benign nodules.
19 pful in better distinguishing malignant from benign nodules.
20 is how to distinguish the malignant from the benign nodules.
21  subset B, including cancers size-matched to benign nodules (1:2 ratio).
22 limation), which included 59 cancers and 163 benign nodules (3-20 mm).
23 s exhibited no significant differences among benign nodules (39.2% [11.2%]), noninvasive follicular t
24 t data were available for 4431 nodules (4315 benign nodules and 116 malignant nodules) from the NLST
25 images to that on 80-kVp images was 2 HU for benign nodules and 3 HU for malignant nodules.
26 ressed in thyroid malignancies compared with benign nodules and normal thyroid tissues.
27 vings of avoiding lobectomy in patients with benign nodules and stability of the nodule on ultrasound
28                             The frequency of benign nodules and the inconsistency of predictions base
29 odules), the specificity was 58% (107 of 185 benign nodules), and the accuracy was 77% (274 of 356 no
30                                              Benign nodules appeared to be almost exclusively associa
31                  Patients with cytologically benign nodules are best followed without thyroxine treat
32                            A large number of benign nodules are reported among smokers in lung cancer
33                             Numerous, mostly benign, nodules are seen in the lungs during screening.
34 % CI: 0.81, 0.98]; P = .11) and size-matched benign nodules (AUC, 0.86 [95% CI: 0.80, 0.91] vs 0.82 [
35  in cancer-enriched cohorts with both random benign nodules (AUC, 0.96 [95% CI: 0.93, 0.99] vs 0.90 [
36                      Seventy-seven of 87 had benign nodules because of resolution or 2-year stability
37 ns in the validation cohorts for cancers and benign nodules compared with the Mayo model were 0.34 (V
38                                  The rate of benign nodule detection is high.
39                                              Benign nodule detection rate is high.
40 necessary tests and surgery in patients with benign nodules, especially those who have limited life e
41 ltiple thresholds were tested to distinguish benign nodules from malignant nodules.
42 uencing on 58 thyroid tumors (28 cancers, 30 benign nodules) from 19 patients with PHTS.
43                                    All eight benign nodules had doubling times of 396 days or greater
44 on cancer-enriched subsets with size-matched benign nodules imaged 1 and 2 years apart from DLCST and
45       However, in addition to a high rate of benign nodules, lung cancer screening detects a large nu
46 able and accurate identification of IPLNs as benign nodules may substantially reduce the number of un
47 557), and lung cancer patients (n=30) versus benign nodules (n=128).
48 sion (negative screening result); calcified, benign nodule (negative screening result); or no nodule
49 differentiated thyroid cancer but not in the benign nodules or a healthy thyroid.
50 (SD 0.67) in malignant and 1.02 (SD 0.06) in benign nodules (P = 0.0099).
51                                         Most benign nodules remain stable in size and remain benign w
52 ize matching (177 -nodules, 59 malignant) of benign nodules selected at random.
53  the finding that variants are also found in benign nodules, testing only GEC suspicious nodules may
54           In subset B (180 malignant and 360 benign nodules), the AUC of the DL algorithm versus the
55 predictive value (NPV) for malignancy of the benign nodules was 98.6%, although no malignant transfor
56                                  The risk of benign nodules was elevated in women (relative risk (RR)
57 of 139 HCCs, 18 non-HCC malignancies, and 39 benign nodules) was performed in a three-reader blinded
58 been paired in diameter with the closest two benign nodules, was used to investigate the amount of tr
59 adiographs of 34 primary lung cancers and 22 benign nodules were digitized with a 0.175-mm pixel size
60                                        Seven benign nodules were resected.
61 that depicted 31 primary lung cancers and 22 benign nodules were used.
62 tegories in more than a third of cancers and benign nodules when compared with conventional risk mode
63 emma is to distinguish between a more common benign nodule, which usually does not require specific t
64 structures, and focal lesions, which include benign nodules with intense uptake in the arterial phase
65 Thin-section CT findings of malignant versus benign nodules with pure GGO (17 vs 12 lesions), mixed G